Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Jun-Qiao An und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Myocardial Ischemia, Hypertension. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Research and Translational Application of Clinical Characteristic Diagnostic and Treatment Techniques in the Capital City 'The Effect of Spleen Transportation…, Beijing Municipal Science and Technology Commission, Zhongguancun Science and Technology Park Administrative Committee, China Academy of Traditional Chinese Medicine Excellent Young Scientific and Technological Talent Cultivation Special Project.
Abstract (Originalsprache)
Aims
The three key and direct risk factors for the significant health issue prevalent worldwide, ischaemic heart disease(IHD), are high fasting plasma glucose (HFPG), high low‐density lipoprotein (HLDL) and high systolic blood pressure (HSBP) in metabolic syndrome (MetS). A comprehensive study is essential to present the most recent global epidemiological trends.
Methods
IHD data attributable to HFPG, HLDL and HSBP (3H) were obtained from the Global Burden of Disease Study (GBD) 2021. The absolute burden was manifested in the number of death cases and disability‐adjusted life years (DALY). The relative burden was quantified through the age‐standardized mortality rate (ASMR) and the age‐standardized DALY rate (ASDR). Estimated annual percentage change (EAPC) was used to measure trends.
Results
HSBP caused the greatest IHD burden, followed by HLDL, which was much higher than HFPG. The IHD burden associated with HLDL and HSBP were more alike and notably different from HFPG. From 1990 to 2021, ASDR for HSBP and HLDL‐related IHD generally declined, with the EAPC of −1.28 (95% CI: −1.34, −1.23) and −1.38 (95% CI: −1.44, −1.33). But the trend was less pronounced for HFPG‐related IHD, with the EAPC of −0.90 (95% CI: −2.25, 0.46). The absolute burden was higher in men under 80 and peaked 5–10 years earlier than women. Compared to HSBP and HLDL, HFPG caused a significant increase in burden in low‐middle and low socio‐demographic index (SDI) regions. The high‐middle SDI region, which originally had the highest burden, showed a clear downward trend after 2005 and was gradually overtaken by the low‐middle region. Eastern Europe, Central Asia, North Africa and the Middle East had the highest burden among the regions with the same SDI level in Europe, Asia and Africa.
Conclusion
The HFPG‐related IHD burden should be managed differently from HSBP and HLDL. Particular attention should be paid to men, older age groups and regions with low‐middle SDI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
ORCID-Profile: Jun-Qiao An
Förderung
- Research and Translational Application of Clinical Characteristic Diagnostic and Treatment Techniques in the Capital City 'The Effect of Spleen Transportation…
- Beijing Municipal Science and Technology Commission, Zhongguancun Science and Technology Park Administrative Committee
- China Academy of Traditional Chinese Medicine Excellent Young Scientific and Technological Talent Cultivation Special Project
- Cardiovascular Disease Wise Diagnosis and Nosocomial Preparation
- Funding Agency China Academy of Traditional Chinese Medicine
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
Zitieren
APA
An, J. Q., Jia, Y. Z., Shi, X. H., He, X., Zhang, J. X., Ren, Y. H., & He, Q. Y. (2025). Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16199
Vancouver
An JQ, Jia YZ, Shi XH, He X, Zhang JX, Ren YH, et al. Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16199
BibTeX
@article{An2025,
author = {An, Jun-Qiao and Jia, Yu-Zhi and Shi, Xiao-Han and He, Xue and Zhang, Jin-Xi and Ren, Yue-Han and He, Qing-Yong},
title = {Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16199}
}
EUVIMED